Consensus Moderna, Inc.

Equities

MRNA

US60770K1079

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-07 pm EDT			5-day change	1st Jan Change
121.1 ^USD	-0.87%		+9.75%	+21.74%

May. 07	UBS Adjusts Moderna Price Target to $151 From $143, Maintains Buy Rating	MT
May. 06	News Highlights : Top Financial Services News of the Day - Monday at 4 PM ET	DJ

Evolution of the average Target Price on Moderna, Inc.

Price target over the last 5 years

History of analyst recommendation changes

e538c6fd029b4bad62.cZqF0lGxzpS75tLQ0gHOUGCOD8oFy05vkg0A621msug.N-7g6hzGtP_BibWy4lC9CTbBbawoqQcE4XRP3i4j5YQdrcaTaOWE3fePiw~633740effe27d01907b80a7d19088ef4

Analyst Recommendations on Moderna, Inc.

UBS Adjusts Moderna Price Target to $151 From $143, Maintains Buy Rating	May. 07	MT
News Highlights : Top Financial Services News of the Day - Monday at 11 AM ET	May. 06	DJ
Moderna Insider Sold Shares Worth $1,663,855, According to a Recent SEC Filing	May. 06	MT
Jefferies Adjusts Price Target on Moderna to $155 From $125	May. 03	MT
Oppenheimer Adjusts Price Target on Moderna to $163 From $142	May. 03	MT
Goldman Sachs Adjusts Price Target on Moderna to $204 From $206	May. 03	MT
Leerink Adjusts Price Target on Moderna to $60 From $59	May. 03	MT
Morgan Stanley Adjusts Price Target on Moderna to $95 From $89	May. 03	MT
Jefferies & Co Adjusts Moderna Price Target to $155 From $125	May. 03	MT
Goldman Sachs Adjusts Moderna Price Target to $204 From $206	May. 03	MT
Morgan Stanley Raises Price Target on Moderna to $95 From $89, Keeps Equalweight Rating	May. 03	MT
RBC Raises Price Target on Moderna to $135 From $125 on 'More Prudent Financial Outlook,' Keeps Outperform Rating	May. 03	MT
ANALYST RECOMMENDATIONS : Alphabet, Amgen, Starbucks, PayPal, Moderna...	May. 03
MODERNA : price target raised by Oddo BHF	May. 03	CF
RBC Raises Price Target on Moderna to $135 From $125	May. 02	MT
Chardan Research Lowers Metagenomi's PT to $17 From $21 on Heels of Announced Termination of Collaboration With Moderna, Keeps Buy Rating	May. 02	MT
Moderna Secures Contract to Supply 12.5 Million COVID-19 Vaccine Doses to Brazil	Apr. 22	MT
Moderna Insider Sold Shares Worth $1,575,300, According to a Recent SEC Filing	Apr. 16	MT
Redburn Adjusts Moderna's Price Target to $117 From $110	Apr. 12	MT
MODERNA : Jefferies confirms its Buy recommendation	Apr. 09	CF
HSBC Downgrades Moderna to Reduce From Hold, Raises Price Target to $86 From $75	Feb. 26	MT
ANALYST RECOMMENDATIONS : AbbVie, Doordash, Eli Lilly, Moderna, Hiscox...	Feb. 26
Canaccord Genuity Raises Moderna's Price Target to $91 From $82, Keeps Hold Rating	Feb. 23	MT
MODERNA : RBC keeps its Buy rating	Jan. 12	ZD
WHO sees 'incredibly low' COVID, flu vaccination rates as cases surge	Jan. 12	RE

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

121.1 USD

Average target price

138.7 USD

Spread / Average Target

+14.54%

High Price Target

310 USD

Spread / Highest target

+156.05%

Low Price Target

60 USD

Spread / Lowest Target

-50.44%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Moderna, Inc.

UBS
Jefferies & Co.
Oppenheimer
Goldman Sachs
Leerink Partners
Morgan Stanley
RBC Capital Markets
Redburn
HSBC
Canaccord Genuity
RBC	Luca Issi
JPMorgan Chase
Deutsche Bank Securities
Argus
TD Cowen
William Blair & Co.
Guggenheim
SVB Securities LLC
Cowen
Chardan Research
Piper Sandler
SVB Leerink
BofA Securities
Wolfe Research
Barclays
Chardan
J.P. Morgan Chase

Ratings for Moderna, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar